Unity Health Toronto: Depressive Disorder, Major trials
The registry lists 18 Depressive Disorder, Major studies with Unity Health Toronto as lead sponsor. 8 are open to participants now and 0 have results posted.
Phase 2 1Phase 3 1Phase 4 3No phase 13(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Functional Electrical Stimulation for MDDNot yet recruitingNCT07629050Not applicable
- Digital Interventions for Adults with Treatment-Resistant Depression: a Pilot StudyRecruitingNCT06732089
- Physical Activity Program for TRDRecruitingNCT06404320Not applicable
- The Impact of Working Memory and Reward Markers on DLPFC Activity in Treatment-resistant DepressionRecruitingNCT06163625Not applicable
- Effect of Suicidality on Social CognitionRecruitingNCT06163612
- Integrated Suicide & Trauma Therapy for Suicide RiskRecruitingNCT05613972Not applicable
- Temporal Interference and DepressionRecruitingNCT05295888Not applicable
- Characterizing Synaptic Density in Treatment Resistant DepressionRecruitingNCT03537794
- Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD)TerminatedNCT06843187Phase 2
- Take-home Functional Electrical Stimulation for MDDActive, not recruitingNCT06261177Not applicable
- Musical Attention Control and Executive Function Training for Adults With MDDCompletedNCT05694156Not applicable
- SMILE Trial - Imaging Sub-StudyCompletedNCT05528718
- Sustained Mood Improvement With Laughing Gas Exposure: A Randomized Controlled Pilot TrialCompletedNCT04957368Phase 4
- Stellate Ganglion Block for Major Depressive Disorder.CompletedNCT04727229Phase 4
- Modafinil's Effects on Cognition in Remitted MDDTerminatedNCT03620253Phase 3
- Identifying the Neural Basis of Capability for SuicideSuspendedNCT03327129
- Dimensional Approach to Evaluate Reward Processing in Major Depressive Disorder Pre- and Post-Desvenlafaxine TreatmentCompletedNCT02859103Phase 4
- Pain, Reward, Attention and Neurocircuitry: Biomarkers of SuicidalityCompletedNCT02811198